Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;2(6):904-908.
doi: 10.3892/mco.2014.356. Epub 2014 Jul 23.

Passive targeting of nanoparticles to cancer: A comprehensive review of the literature

Remon Bazak  1 , Mohamad Houri  2 , Samar El Achy  3 , Wael Hussein  1 , Tamer Refaat  4
Affiliations

Passive targeting of nanoparticles to cancer: A comprehensive review of the literature

Remon Bazak et al. Mol Clin Oncol. 2014 Nov.

Abstract

Cancer remains the one of the most common causes of mortality in humans; thus, cancer treatment is currently a major focus of investigation. Researchers worldwide have been searching for the optimal treatment (the 'magic bullet') that will selectively target cancer, without afflicting significant morbidity. Recent advances in cancer nanotechnology have raised exciting opportunities for specific drug delivery by an emerging class of nanotherapeutics that may be targeted to neoplastic cells, thereby offering a major advantage over conventional chemotherapeutic agents. There are two ways by which targeting of nanoparticles may be achieved, namely passive and active targeting. The aim of this study was to provide a comprehensive review of the literature focusing on passive targeting.

Keywords: cancer; nanoparticles; passive targeting.

PubMed Disclaimer

References

    1. Greish K. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target. 2007;15:457–464. - PubMed
    1. Greish K. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol. 2010;624:25–37. - PubMed
    1. LaRocque J, Bharali DJ, Mousa SA. Cancer detection and treatment: the role of nanomedicines. Mol Biotechnol. 2009;42:358–366. - PubMed
    1. Wang X, Wang Y, Chen ZG, Shin DM. Advances of cancer therapy by nanotechnology. Cancer Res Treat. 2009;41:1–11. - PMC - PubMed
    1. Kreuter J. Nanoparticles - a historical perspective. Int J Pharm. 2007;331:1–10. - PubMed